Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARROWHEAD RESEARCH CORP

 SummaryChartsNewsRatingsCalendarCompany 
Company
Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic... 
More about the company
Ratings of Arrowhead Research Corp
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ARROWHEAD RESEARCH CORP
07/14ARROWHEAD PHARMACEUTICALS : Reports Inducement Grants Under NASDAQ Listing Rule ..
BU
07/14ARROWHEAD PHARMACEUTICALS : to Webcast Fiscal 2021 Third Quarter Results
BU
07/06ARROWHEAD PHARMACEUTICALS : Says Interim Phase 1 Data Show Potentially Early Sig..
MT
07/06ARROWHEAD PHARMACEUTICALS : Announces Positive Interim Results from Phase 1b Stu..
BU
07/06Arrowhead Pharmaceuticals, Inc. Announces Positive Interim Results from Phase..
CI
07/05ARROWHEAD PHARMACEUTICALS : Pauses ARO-ENaC Phase 1/2 Clinical Study
AQ
07/05WALL STREET STOCK EXCHANGE : World indexes hover close to record highs
07/05ANALYST RECOMMENDATIONS : Anthem, GlaxoSmithKline, Flutter, IMI, Workspace...
07/02Alector, Virgin Galactic rise; Arrowhead, Boeing fall
AQ
07/02SECTOR UPDATE : Health Care Stocks Posting Gains Ahead of Friday Close
MT
07/02SECTOR UPDATE : Health Care Stocks Advance, Biotechs Down Friday
MT
07/02ARROWHEAD PHARMACEUTICALS : Piper Sandler Adjusts Arrowhead Pharmaceuticals PT t..
MT
07/02SECTOR UPDATE : Health Care Stocks Advance Pre-Bell Friday
MT
07/02Wall Street Sees Positive Open as Nonfarm Payrolls Rise More Than Expected
MT
07/02ARROWHEAD PHARMACEUTICALS : Pauses ARO-ENaC Phase 1/2 Clinical Study on Toxicolo..
MT
More news
News in other languages on ARROWHEAD RESEARCH CORP
2018WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2018Arrowhead conclut un accord avec J&J, son titre bondit
More news
Analyst Recommendations on ARROWHEAD RESEARCH CORP
More recommendations
Chart ARROWHEAD RESEARCH CORP
Duration : Period :
Arrowhead Research Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Christopher Richard Anzalone President, Chief Executive Officer & Director
Kenneth Allen Myszkowski Chief Financial Officer
Douglass B. Given Chairman
Javier San Martin Chief Medical Officer
Jeff Ketelhut Vice President-Information Technology & Systems
Sector and Competitors
1st jan.Capi. (M$)
ARROWHEAD RESEARCH CORP-15.77%6 864
GILEAD SCIENCES, INC.18.31%86 451
BIONTECH SE248.38%68 592
WUXI APPTEC CO., LTD.28.80%64 659
REGENERON PHARMACEUTICALS20.26%60 167
VERTEX PHARMACEUTICALS-14.17%52 511